Chou Associates Management
13F Holdings and Portfolio Analysis
Francis Chou 2016 Q3 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
Chou Associates Management Overview
Chou Associates Management held 27 stocks in 2016 Q3, with total market value around $0.27B.
Chou Associates Management's top five holdings in 2016 Q3: VALEANT PHARMACEUTICALS INTL 13.14%, BERKSHIRE HATHAWAY INC CL A(BRK.A) 12.00%, JPMORGAN CHASE & CO 10.27%, RESOLUTE FST PRODS INC 8.58%, NOKIA OYJ COMMON STOCK(NOK) 8.03%.
- Portfolio Value
- $0.27B
- Current Holdings
- 27 stocks
- New / Increased
- 0 / 0
- Reduced / Exited
- 0 / 0
Current Holdings
| 1 | VALEANT PHARMACEUTICALS INTLCUSIP 91911K102 | 0.04 | 13.14% | 1.45 - | $24.55 | - | $17.56 | 0.00 | 0.75 | +$0.01B+39.83% | Held |
| 2 | BERKSHIRE HATHAWAY INC CL ABRK.A | 0.03 | 12.00% | 0.00 - | $216220.00 | $705400.23 +226.24% | $168600.00 | 0.00 | 3.50 | +$0.08B+318.39% | Held |
| 3 | JPMORGAN CHASE & COCUSIP 46634E114 | 0.03 | 10.27% | 1.13 - | $24.63 | - | $20.81 | 0.00 | 2.00 | +$0.00B+18.37% | Held |
| 4 | RESOLUTE FST PRODS INCCUSIP 76117W109 | 0.02 | 8.58% | 4.90 - | $4.73 | - | $12.24 | 0.00 | 3.50 | -$0.04B-61.34% | Held |
| 5 | NOKIA OYJ COMMON STOCKNOK | 0.02 | 8.03% | 3.75 - | $5.79 | - | $3.74 | 0.00 | 3.50 | +$0.01B+54.81% | Held |
| 6 | Citigroup Inc.C | 0.02 | 7.17% | 0.41 - | $47.23 | $97.52 +106.48% | $47.97 | 0.00 | 3.50 | +$0.02B+103.29% | Held |
| 7 | SEARS HLDGS CORPCUSIP 812350106 | 0.02 | 6.07% | 1.43 - | $11.46 | - | $26.53 | 0.00 | 3.50 | -$0.02B-56.80% | Held |
| 8 | SanofiSNY | 0.02 | 5.79% | 0.41 - | $38.19 | $49.22 +28.88% | $51.51 | 0.00 | 3.50 | -$0.00B-4.45% | Held |
| 9 | WELLS FARGO & CO NEWCUSIP 949746119 | 0.01 | 4.61% | 1.00 - | $12.48 | - | $13.67 | 0.00 | 3.50 | -$0.00B-8.71% | Held |
| 10 | The Goldman Sachs Group, Inc.GS | 0.01 | 4.48% | 0.07 - | $161.27 | $751.53 +366.02% | $151.25 | 0.00 | 3.50 | +$0.05B+396.87% | Held |
| 11 | OVERSTOCK COM INC DELCUSIP 690370101 | 0.01 | 3.30% | 0.58 - | $15.32 | - | $28.20 | 0.00 | 3.50 | -$0.01B-45.68% | Held |
| 12 | MBIA INC COMMBI | 0.01 | 3.12% | 1.08 - | $7.79 | - | $13.31 | 0.00 | 3.50 | -$0.01B-41.47% | Held |
| 13 | ASCENT CAP GROUP INCCUSIP 043632108 | 0.01 | 2.92% | 0.34 - | $23.17 | - | $15.39 | 0.00 | 0.50 | +$0.00B+50.54% | Held |
| 14 | SEARS HOMETOWN & OUTLET STORCUSIP 812362101 | 0.01 | 2.41% | 1.32 - | $4.93 | - | $11.59 | 0.00 | 2.25 | -$0.01B-57.47% | Held |
| 15 | BLACKBERRY LTD COMBB | 0.00 | 1.56% | 0.53 - | $7.97 | - | $7.89 | 0.00 | 3.25 | +$0.00B+1.01% | Held |
| 16 | BANK AMER CORPCUSIP 060505146 | 0.00 | 1.43% | 0.84 - | $4.62 | - | $5.46 | 0.00 | 3.50 | -$0.00B-15.39% | Held |
| 17 | COMPUCREDIT HLDGS CORPCUSIP 20478NAD2 | 0.00 | 1.21% | 7.80 - | $0.42 | - | $0.44 | 0.00 | 0.50 | -$0.00B-4.55% | Held |
| 18 | ASCENT CAPITAL GROUP INC CV SR UNSEC NTCUSIP 043632AA6可转换债券 | 0.00 | 0.71% | 2.68 - | $0.71 | - | $1.01 | 0.00 | 2.25 | -$0.00B-29.79% | Held |
| 19 | SEARS CDA INCCUSIP 81234D109 | 0.00 | 0.70% | 0.78 - | $2.46 | - | $9.64 | 0.00 | 2.00 | -$0.01B-74.54% | Held |
| 20 | CHICAGO BRIDGE & IRON CO N V N Y REGISTRY SHCBI | 0.00 | 0.70% | 0.07 - | $28.04 | - | $34.64 | 0.00 | 0.50 | -$0.00B-19.05% | Held |
| 21 | RYANAIR HOLDINGS PLC SPONSORED ADSRYAAY | 0.00 | 0.46% | 0.02 - | $75.05 | - | $86.46 | 0.00 | 1.00 | -$0.00B-13.19% | Held |
| 22 | POSCO HOLDINGS INC -SPON ADRPKX | 0.00 | 0.40% | 0.02 - | $51.10 | - | $35.05 | 0.00 | 1.25 | +$0.00B+45.79% | Held |
| 23 | AstraZeneca PLCAZN | 0.00 | 0.31% | 0.01 - | $64.85 | $84.69 +30.60% | $58.92 | 0.00 | 3.00 | +$0.00B+43.73% | Held |
| 24 | China Yuchai International LimitedCYD | 0.00 | 0.29% | 0.07 - | $10.85 | $34.95 +222.12% | $5.87 | 0.00 | 3.50 | +$0.00B+495.02% | Held |
| 25 | GSK plcGSK | 0.00 | 0.14% | 0.02 - | $21.28 | $44.09 +107.23% | $26.56 | 0.00 | 3.00 | +$0.00B+66.04% | Held |
Showing 1-25 of 27
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.